Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.07B |
| 2 |
SPCX
SpaceX
SPCX
|
+$2.99B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$1.11B |
| 4 |
Microsoft
MSFT
|
+$584M |
| 5 |
Bloom Energy
BE
|
+$547M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$1.65B |
| 2 |
Marvell Technology
MRVL
|
+$1.16B |
| 3 |
Apple
AAPL
|
+$1.12B |
| 4 |
SNDK
Sandisk
SNDK
|
+$1.11B |
| 5 |
Micron Technology
MU
|
+$816M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.52% |
| 2 | Industrials | 7.53% |
| 3 | Financials | 5.78% |
| 4 | Healthcare | 5.7% |
| 5 | Consumer Discretionary | 3.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GTM
1976
ZoomInfo Technologies
GTM
$1.14B
| $12.7M | ﹤0.01% |
4,324,554
+3,103,513
| +254% | +$14M |
|
1977
Alpha and Omega Semiconductor
AOSL
$783M
| $12.7M | ﹤0.01% |
267,648
+69,866
| +35% | +$2.81M |
|
1978
Immunovant
IMVT
$8.95B
| $12.7M | ﹤0.01% |
+328,678
| New | +$10M |
|
1979
QuidelOrtho
QDEL
$994M
| $12.7M | ﹤0.01% |
722,480
+440,263
| +156% | +$5.82M |
|
1980
Dave Inc
DAVE
$4.53B
| $12.6M | ﹤0.01% |
33,917
-8,173
| -19% | -$2.12M |
|
|
CALY
1981
Callaway Golf Company
CALY
$2.82B
| $12.6M | ﹤0.01% |
+672,463
| New | +$10.5M |
|
1982
J.M. Smucker
SJM
$13.5B
| $12.6M | ﹤0.01% |
112,258
-179,437
| -62% | -$18.3M |
|
1983
PUT
Diamondback Energy
FANG
$57.6B
| $12.6M | ﹤0.01% |
71,800
+22,500
| +46% | +$4.36M |
|
1984
Under Armour
UAA
$2.31B
| $12.6M | ﹤0.01% |
1,973,897
-1,388,697
| -41% | -$8.23M |
|
1985
FMC
FMC
$1.41B
| $12.6M | ﹤0.01% |
1,094,883
-20,348
| -2% | -$284K |
|
1986
PUT
Colgate-Palmolive
CL
$73.8B
| $12.6M | ﹤0.01% |
137,300
-15,300
| -10% | -$1.34M |
|
1987
PTC
PTC
$16.7B
| $12.5M | ﹤0.01% |
110,407
+31,197
| +39% | +$4.21M |
|
1988
Codexis
CDXS
$182M
| $12.5M | ﹤0.01% |
5,549,139
+1,551,009
| +39% | +$3.86M |
|
|
DFTX
1989
Definium Therapeutics
DFTX
$5.81B
| $12.5M | ﹤0.01% |
266,076
-580,820
| -69% | -$14.4M |
|
|
MBX
1990
MBX Biosciences
MBX
$3.2B
| $12.5M | ﹤0.01% |
226,151
-338,264
| -60% | -$11.8M |
|
1991
CDW
CDW
$16.6B
| $12.5M | ﹤0.01% |
88,615
+55,353
| +166% | +$6.95M |
|
1992
MarketAxess Holdings
MKTX
$5.72B
| $12.4M | ﹤0.01% |
109,590
-977,598
| -90% | -$139M |
|
1993
Evolus
EOLS
$580M
| $12.4M | ﹤0.01% |
1,787,929
+326,770
| +22% | +$1.93M |
|
1994
Petrobras
PBR
$120B
| $12.4M | ﹤0.01% |
767,639
-209,977
| -21% | -$4.1M |
|
1995
PUT
Cintas
CTAS
$83B
| $12.4M | ﹤0.01% |
72,900
+59,000
| +424% | +$10.2M |
|
1996
MoonLake Immunotherapeutics
MLTX
$1.31B
| $12.4M | ﹤0.01% |
636,187
+60,095
| +10% | +$1.09M |
|
1997
Expeditors International
EXPD
$24.4B
| $12.4M | ﹤0.01% |
75,978
-274,665
| -78% | -$42.5M |
|
|
MTAL.U
1998
Metals Acquisition Corp II Units
MTAL.U
| $12.4M | ﹤0.01% |
1,130,000
-800,000
| -41% | -$8.35M |
|
1999
iShares US Medical Devices ETF
IHI
$3.45B
| $12.4M | ﹤0.01% |
+250,020
| New | +$12.7M |
|
2000
Tonix Pharmaceuticals
TNXP
$214M
| $12.3M | ﹤0.01% |
966,932
+747,259
| +340% | +$9.64M |
|
Similar funds
Israel Englander's Q2 2026 Portfolio in Review
As of Q2 2026, Israel Englander held 6,628 positions worth $276B, up 15% from $240B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander's Q2 2026 filing shows 986 new, 2,006 increased, 2,341 reduced and 833 closed positions. Its largest new stake was SpaceX: 17,604,863 shares worth $2.98B. The largest sale was State Street SPDR Portfolio S&P 500 ETF, an estimated $1.65B.
By sector, the portfolio is most concentrated in Technology at 9.5% of assets, up from 9.1% a quarter earlier, followed by Industrials and Financials.
- Israel Englander's largest Q2 2026 buy was SpaceX: 17,604,863 shares worth $2.98B.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $3.07B increase.
- Israel Englander's biggest Q2 2026 reduction was Marvell Technology, cutting an estimated $1.16B.
- Israel Englander fully exited State Street SPDR Portfolio S&P 500 ETF in Q2 2026, selling an estimated $1.65B.
- Israel Englander's ten largest holdings make up 18% of its $276B portfolio in Q2 2026.
- Israel Englander opened 986 new positions and closed 833 in Q2 2026.
- Israel Englander's portfolio value rose 15% quarter-over-quarter to $276B.
Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.